BGI
In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More
News items for the week of Jan. 10, 2022.
Chinese Study Uncovers Ties Between Blood Metabolites, Gut Microbes
A team led by researchers at BGI-Shenzhen used Mendelian randomization approaches to examine the causal relationships between blood metabolites and the gut microbiome.
Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent
BGI's CoolMPS sequencing chemistry was found to infringe four of Illumina's patents, but claims from two Illumina patents were invalidated.
BGI Genomics Program Seeks to Validate Signatera Test for Colorectal Cancer Patients in China
Premium
The molecular residual disease test from Natera was first made available to biopharmaceutical customers and clinicians across China in June.
Although demand for the firm's COVID-19 testing declined in H1, other diagnostic areas and its international business have grown.